BioNTech SE (BNTX) Misses Q1 EPS by 18c

BioNTech SE (NASDAQ: BNTX) reported Q1 EPS of (EUR1.31), EUR0.18 worse than the analyst estimate of (EUR1.13). Revenue for the quarter came in at EUR187.6 million versus the consensus estimate of EUR305 million.

BioNTech still expects group revenues for the full 2024 financial year to be in the range of €2.5 billion to €3.1 billion

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers
• Lemonade cuts quota share cession to 18% in reinsurance renewal
• Resolutions of the Annual General Meeting of Shareholders of Arco Vara AS